Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Baniel

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2020
Dynamic <sup>68</sup>Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective StudyShay Golan, Tzach Aviv, David Groshar, et al.
Urology|February 7, 2007
Urothelial carcinoma of the prostateJuan Palou, Jack Baniel, Laurence Klotz, et al.
Prostate Cancer and Prostatic Diseases|August 2, 2020
Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonistDavid Margel, Yaara Ber, Avivit Peer, et al.
World Journal of Urology|February 16, 2023
Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasiaRan Katz, Christina Sze, Ananth Punyala, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Familial Cancer|September 1, 2006
The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in IsraelEfrat Dagan, Yael Laitman, Nurit Levanon, et al.
Urologic Oncology|July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyEric A Klein, Alan Partin, Yair Lotan, et al.
Harefuah|June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
Hellenic Urology|March 13, 2026
A narrative review of the current state of circulating tumor cells in prostate cancer diagnosticStanislav Vovdenko, Andrey Bazarkin, Andrey Morozov, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2020
Dynamic <sup>68</sup>Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective StudyShay Golan, Tzach Aviv, David Groshar, et al.
Urology|February 7, 2007
Urothelial carcinoma of the prostateJuan Palou, Jack Baniel, Laurence Klotz, et al.
Prostate Cancer and Prostatic Diseases|August 2, 2020
Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonistDavid Margel, Yaara Ber, Avivit Peer, et al.
World Journal of Urology|February 16, 2023
Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasiaRan Katz, Christina Sze, Ananth Punyala, et al.
The Journal of Urology|July 14, 2021
Reply by AuthorsKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology|May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate CancerKarin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Familial Cancer|September 1, 2006
The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in IsraelEfrat Dagan, Yael Laitman, Nurit Levanon, et al.
Urologic Oncology|July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyEric A Klein, Alan Partin, Yair Lotan, et al.
Harefuah|June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
Hellenic Urology|March 13, 2026
A narrative review of the current state of circulating tumor cells in prostate cancer diagnosticStanislav Vovdenko, Andrey Bazarkin, Andrey Morozov, et al.
Pageof 15